Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 11
2022 15
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean viral kumar (2 results)?
Nuclear receptors in oral cancer-Emerging players in tumorigenesis.
Gangwar SK, Kumar A, Jose S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Gangwar SK, et al. Among authors: kumar a. Cancer Lett. 2022 Jun 28;536:215666. doi: 10.1016/j.canlet.2022.215666. Epub 2022 Mar 29. Cancer Lett. 2022. PMID: 35364221 Review.
MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.
Rishabh K, Khadilkar S, Kumar A, Kalra I, Kumar AP, Kunnumakkara AB. Rishabh K, et al. Among authors: kumar a. Int J Mol Sci. 2021 Mar 4;22(5):2561. doi: 10.3390/ijms22052561. Int J Mol Sci. 2021. PMID: 33806361 Free PMC article. Review.
Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.
Gangwar SK, Kumar A, Yap KC, Jose S, Parama D, Sethi G, Kumar AP, Kunnumakkara AB. Gangwar SK, et al. Among authors: kumar a. Pharmaceuticals (Basel). 2022 May 18;15(5):624. doi: 10.3390/ph15050624. Pharmaceuticals (Basel). 2022. PMID: 35631448 Free PMC article. Review.
Natural compounds targeting nuclear receptors for effective cancer therapy.
Hegde M, Girisa S, Naliyadhara N, Kumar A, Alqahtani MS, Abbas M, Mohan CD, Warrier S, Hui KM, Rangappa KS, Sethi G, Kunnumakkara AB. Hegde M, et al. Among authors: kumar a. Cancer Metastasis Rev. 2023 Sep;42(3):765-822. doi: 10.1007/s10555-022-10068-w. Epub 2022 Dec 8. Cancer Metastasis Rev. 2023. PMID: 36482154 Review.
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.
Kunnumakkara AB, Hegde M, Parama D, Girisa S, Kumar A, Daimary UD, Garodia P, Yenisetti SC, Oommen OV, Aggarwal BB. Kunnumakkara AB, et al. Among authors: kumar a. ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14. ACS Pharmacol Transl Sci. 2023. PMID: 37082752 Free PMC article. Review.
The promising potential of piperlongumine as an emerging therapeutics for cancer.
Parama D, Rana V, Girisa S, Verma E, Daimary UD, Thakur KK, Kumar A, Kunnumakkara AB. Parama D, et al. Among authors: kumar a. Explor Target Antitumor Ther. 2021;2(4):323-354. doi: 10.37349/etat.2021.00049. Epub 2021 Aug 30. Explor Target Antitumor Ther. 2021. PMID: 36046754 Free PMC article. Review.
Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy.
Khatoon E, Parama D, Kumar A, Alqahtani MS, Abbas M, Girisa S, Sethi G, Kunnumakkara AB. Khatoon E, et al. Among authors: kumar a. Life Sci. 2022 Oct 1;306:120827. doi: 10.1016/j.lfs.2022.120827. Epub 2022 Jul 27. Life Sci. 2022. PMID: 35907493 Review.
The Journey of Resveratrol from Vineyards to Clinics.
Venkat R, Verma E, Daimary UD, Kumar A, Girisa S, Dutta U, Ahn KS, Kunnumakkara AB. Venkat R, et al. Among authors: kumar a. Cancer Invest. 2023 Feb;41(2):183-220. doi: 10.1080/07357907.2022.2115057. Epub 2022 Sep 26. Cancer Invest. 2023. PMID: 35993769
36 results